Dr. Reddys Labs (RDY) Tops Q1 EPS by 1c

Dr. Reddys Labs (NYSE: RDY) reported Q1 EPS of $0.22, $0.01 better than the analyst estimate of $0.21. Revenue for the quarter came in at $996 million versus the consensus estimate of $961.31 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
• BMO Capital Starts Analog Devices (ADI) at Outperform
• UBS Downgrades Vicinity Centers (VCX:AU) (CNRAF) to Neutral